Milestone Asset Management LLC Purchases New Holdings in HealthEquity, Inc. $HQY

Milestone Asset Management LLC acquired a new position in HealthEquity, Inc. (NASDAQ:HQYFree Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 10,925 shares of the company’s stock, valued at approximately $1,035,000.

Other large investors have also modified their holdings of the company. Farther Finance Advisors LLC raised its holdings in shares of HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after buying an additional 172 shares during the period. WPG Advisers LLC bought a new position in HealthEquity in the 1st quarter valued at $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in HealthEquity in the second quarter worth $33,000. Cullen Frost Bankers Inc. lifted its position in shares of HealthEquity by 172.3% during the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after purchasing an additional 224 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in shares of HealthEquity by 176.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock valued at $58,000 after purchasing an additional 418 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president directly owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the sale, the executive vice president owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 17,240 shares of company stock valued at $1,640,164 in the last 90 days. Insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on HQY. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $120.00 price objective on shares of HealthEquity in a report on Friday, December 5th. BTIG Research reaffirmed a “buy” rating and set a $130.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. Jefferies Financial Group raised their price objective on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a report on Wednesday, September 3rd. Finally, Citigroup reaffirmed an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $120.27.

Get Our Latest Report on HQY

HealthEquity Trading Down 0.2%

Shares of NASDAQ:HQY opened at $92.47 on Thursday. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65. The business’s fifty day simple moving average is $97.21 and its 200-day simple moving average is $96.03. The company has a market capitalization of $7.90 billion, a PE ratio of 42.42, a P/E/G ratio of 1.34 and a beta of 0.18. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQYGet Free Report) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million during the quarter, compared to analysts’ expectations of $320.92 million. During the same period in the prior year, the business posted $0.78 EPS. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Featured Stories

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.